NH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.3
| Stock Code | NH | Market Cap | 35,934 Cr. | Current Price | 1,758 ₹ | High / Low | 2,372 ₹ |
| Stock P/E | 77.4 | Book Value | 114 ₹ | Dividend Yield | 0.26 % | ROCE | 19.4 % |
| ROE | 21.0 % | Face Value | 10.0 ₹ | DMA 50 | 1,843 ₹ | DMA 200 | 1,782 ₹ |
| Chg in FII Hold | 0.61 % | Chg in DII Hold | 0.15 % | PAT Qtr | 138 Cr. | PAT Prev Qtr | 87.4 Cr. |
| RSI | 40.1 | MACD | -35.4 | Volume | 4,16,741 | Avg Vol 1Wk | 3,29,443 |
| Low price | 1,296 ₹ | High price | 2,372 ₹ | PEG Ratio | 1.67 | Debt to equity | 0.69 |
| 52w Index | 42.9 % | Qtr Profit Var | 30.6 % | EPS | 22.7 ₹ | Industry PE | 44.0 |
📊 Analysis: NH shows weak-to-moderate intraday potential. Current price (1,758 ₹) is below both 50 DMA (1,843 ₹) and 200 DMA (1,782 ₹), indicating short-term weakness. RSI at 40.1 suggests oversold territory, while MACD (-35.4) confirms bearish momentum. Volume (4.16L) is above average (3.29L), showing active participation, but price action remains pressured.
💰 Optimal Buy Price: 1,740 ₹ – 1,760 ₹ (near support zone)
📈 Profit-Taking Levels: 1,790 ₹ – 1,820 ₹
📉 Stop-Loss / Loss Protection: 1,720 ₹
⏱️ If Already Holding: Exit intraday if price fails to hold above 1,740 ₹ or if RSI dips below 38. Consider booking profits if price approaches 1,790–1,820 ₹ with weakening momentum or reversal signals.
Positive
- Strong ROE (21.0%) and ROCE (19.4%) indicate operational efficiency.
- EPS of 22.7 ₹ reflects solid earnings base.
- Quarterly PAT improved (138 Cr. vs 87.4 Cr.), showing growth.
- FII holdings increased (+0.61%) and DII holdings increased (+0.15%), reflecting institutional confidence.
- Volume above average indicates active trader interest.
Limitation
- High P/E (77.4) compared to industry average (44.0) signals overvaluation.
- RSI near oversold zone but MACD strongly negative, confirming bearish momentum.
- Debt-to-equity ratio of 0.69 indicates moderate leverage risk.
- Dividend yield of 0.26% is relatively low.
Company Negative News
- Stock trading below both DMA 50 and DMA 200, confirming short-term weakness.
- 52-week index at 42.9% shows weak recovery from highs.
Company Positive News
- Quarterly profit variation (+30.6%) highlights earnings momentum.
- Institutional buying (FII and DII increases) supports fundamentals.
Industry
- Industry P/E at 44.0 is lower than NH’s (77.4), suggesting sector is cheaper.
- Healthcare sector remains resilient with long-term demand growth, though valuations are stretched.
Conclusion
⚖️ NH is a weak-to-moderate candidate for intraday trading today. Fundamentals show earnings growth and institutional support, but technical indicators highlight short-term weakness and overvaluation. Best suited for cautious scalps near support with tight stop-loss discipline and profit booking around 1,790–1,820 ₹.
Would you like me to also prepare a workflow-ready HTML template with peer benchmarking overlays (e.g., comparing NH with Apollo Hospitals, Fortis, and Max Healthcare) so you can integrate sector-relative strength into your intraday reports?